Literature DB >> 2142348

[The characteristics of the transformed phenotype and the expression of indicator plasmids in the cells of rat embryonic fibroblasts immortalized by oncogene E1Aad5 and transformed by oncogenes E1Aad5+c-Ha-ras].

T V Pospelova, T V Kisliakova, A V Medvedev, S B Svetlikova, V A Pospelov.   

Abstract

Rat embryonal fibroblasts of the second passage have been immortalized or transformed with the E1A region of the human adenovirus type 5 and the cloned c-Ha-ras oncogene. Several cell lines obtained greatly differ according to the criteria of the transformed phenotype: saturation cell density, the ability to be cloned on a substrate and in soft agar, the ability to give tumors in nude mice. We have transiently transfected these immortalized and transformed cell lines with CAT-plasmids containing the CAT gene under the control of promoters of the "cell-cycle dependent" genes (human hsp70 and protooncogene c-fos). The results showed that the expression of hsp-CAT and fos-CAT plasmids differed in great extent depending on whether the cells were immortalized (E1Aad5) or transformed (E1Aad5+Ha-ras). The role of cellular genes and cellular transcription factors influencing the expression of transiently transfected CAT-plasmids has been discussed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2142348

Source DB:  PubMed          Journal:  Tsitologiia        ISSN: 0041-3771


  2 in total

1.  E1A + cHa-ras transformed rat embryo fibroblast cells are characterized by high and constitutive DNA binding activities of AP-1 dimers with significantly altered composition.

Authors:  T V Pospelova; A V Medvedev; A N Kukushkin; S B Svetlikova; A J van der Eb; J C Dorsman; V A Pospelov
Journal:  Gene Expr       Date:  1999

2.  Ras Participates in the Regulation of the Stability of Adenoviral Protein E1A via MAP-kinase ERK.

Authors:  A V Morshneva; O O Gnedina; D N Kindt; M V Igotti
Journal:  Acta Naturae       Date:  2022 Apr-Jun       Impact factor: 2.204

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.